Bong-Yong Lee
Directeur/Bestuurslid bij Neomics Co., Ltd.
Oorsprong van het eerstegraads netwerk van Bong-Yong Lee
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Neomics Co., Ltd.
Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Neomics Co., Ltd. develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer. It provides services of custom antibody and protein production and offers antibody groups including in-house antibodies from aminoacyl-tRNA synthesize. The company was founded by Chi Uk In in 2005 and is headquartered in Seoul, South Korea.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Bong-Yong Lee via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
REPROS THERAPEUTICS INC | Pharmaceuticals: Major | President | |
Carnegie Mellon University
Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin | |
MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
Brown University | College/University | Doctorate Degree | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
KYUNGBANGCO.LTD | Textiles | Chief Executive Officer | |
HANALL BIOPHARMA CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Illinois | College/University | Doctorate Degree | |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance RBC Capital Markets LLC is a full-service brokerage and financial services firm headquartered in New York City. They are a direct subsidiary of RBC USA Holdco Corp. and a wholly-owned indirect subsidiary of Royal Bank of Canada (TSE, NYSE: RY). Founded in 2010, the firm is comprised of 3 major business lines: the Private Client Group, the Fixed-Income Group and the Clearing and Execution Services Group. The Private Client Group serves individual investors, while the Fixed-Income Group provides services to institutions, municipalities and non-profit organizations. The Clearing and Execution Services Group is a provider of clearing and execution services to independent brokers/dealers throughout the US. RBC Capital Markets focuses on the following sectors: communications, media, consumer/retail, diversified industries, energy, financial institutions, forest products, healthcare, infrastructure finance, mining & metals, real estate, social infrastructure, technology and the US municipal markets. | Investment Banks/Brokers | Analyst-Equity | |
Georgetown University | College/University | Undergraduate Degree | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Yonsei University | College/University | Undergraduate Degree | |
Seoul National University | College/University | Graduate Degree | |
Radboud University Nijmegen | College/University | Doctorate Degree | |
Korea University | College/University | Undergraduate Degree | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SK INNOVATION CO., LTD. | Oil Refining/Marketing | President | |
IMAGENE Co., Ltd.
IMAGENE Co., Ltd. BiotechnologyHealth Technology IMAGENE Co., Ltd. researches and develops treatment for cancer and infectious diseases. Its products include antibody43, chiral building blocks, and aminoacyl-tRNA synthetase inhibitors. The company was founded on December 1, 1997 and is headquartered in Yongin, South Korea. | Biotechnology | Chief Executive Officer | |
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/
Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ Investment ManagersFinance Mirae Asset Venture Investment Co., Ltd. /Venture Capital/ (Mirae Asset Venture) is a private equity & venture capital subsidiary of Mirae Asset Venture Investment Co., Ltd. founded in 1999. The firm is headquartered in Seongnam, South Korea with an office in Seoul. | Investment Managers | Private Equity Investor | |
BioSight Ltd.
BioSight Ltd. Miscellaneous Commercial ServicesCommercial Services BioSight Ltd. is a clinical stage biotechnology company engaging in the development of therapeutics for hematological malignancies and disorders. The company was founded by Stela Gengrinovitchan and Mark Gengrinovitch on November 10, 1999 and is headquartered in Lod, Isreal. | Miscellaneous Commercial Services | Director/Board Member | |
SK Energy Co., Ltd.
SK Energy Co., Ltd. Oil Refining/MarketingEnergy Minerals SK Energy Co., Ltd. engages in supplying petroleum and related products. It supplies kerosene, diesel, petrol, liquefied petroleum gas and asphalt. The company was founded by Kim Jun on January 4, 2011 and is headquartered in Seoul, South Korea. | Oil Refining/Marketing | Founder | |
The University of Connecticut School of Medicine | College/University | Doctorate Degree | |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Chairman | |
Korean Drug Research Association | Director/Board Member | ||
Health Prime International LLC
Health Prime International LLC Miscellaneous Commercial ServicesCommercial Services Health Prime International LLC engages in the supply of outsourced medical billing services. It offers PrimeEHR, PrimeQuality, PrimeTranscription, PrimeContact, PrimeConsult, PrimeSmartCharge, and PrimeMarketing. The company was founded by Vinod K. Shah in 2004 and is headquartered in National Harbor, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member | |
ARVINAS, INC. | Biotechnology | Director/Board Member | |
CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member | |
NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member | |
ONCORUS, INC. | Biotechnology | Director/Board Member | |
BRIDGE BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
YOUCEL, Inc.
YOUCEL, Inc. BiotechnologyHealth Technology YOUCEL, Inc. engages in the manufacture and sale of cosmetics and pharmaceutical products. Its products include facial masks, cleansers, and hair and skin care products. The company was founded on August 18, 2008 and is headquartered in Iksan-si, South Korea. | Biotechnology | Director/Board Member | |
Alliance for Clinical Research Excellence & Safety
Alliance for Clinical Research Excellence & Safety Miscellaneous Commercial ServicesCommercial Services Alliance for Clinical Research Excellence & Safety is a non-governmental organization that builds, implements, and maintains comprehensive systems. The non-profit company is based in Cambridge, MA. The company was founded by Greg Koski. | Miscellaneous Commercial Services | Director/Board Member | |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
REPARE THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Auron Therapeutics, Inc.
Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auron Therapeutics, Inc. operates as a biotechnology company. It aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. The company was founded by Kate Yen, Matt Vander Heiden, Ross Levine, and Eytan Stein and is headquartered in Wellesley, MA. | Miscellaneous Commercial Services | Chairman | |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Photys Therapeutics, Inc.
Photys Therapeutics, Inc. Medical SpecialtiesHealth Technology Photys Therapeutics, Inc. is a company based in Cambridge, MA that was founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women's Hospital and the Broad Institute of MIT and Harvard. The company is advancing phosphorylation inducing chimeric small molecules (PHICs), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to treat a range of diseases including cancer, immune, metabolic, and rare diseases. PHICs enhance the pairing of specific kinases with disease target proteins, inducing precise phosphorylation at native and/or non-native sites, modulating key functions including activation, stabilization, trafficking, localization, phospho-antigen presentation, inactivation, degradation, and interactions of proteins. The company's approach unlocks diverse classes of targets, developing a new class of medicines for precise control of protein function. The company was founded by Amit Choudhary, David Steinberg, Edward Holson, Lizzie Ngo. David Steinberg has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
Bioimpact Capital LLC
Bioimpact Capital LLC Investment ManagersFinance MPM BioImpact LLC (MPM BioImpact) is a venture capital firm a subsidiary of MPM Bioimpact Inc founded in 1996. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
CARISMA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Crossbow Therapeutics, Inc.
Crossbow Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Crossbow Therapeutics, Inc. is a biotechnology company that aims to improve the lives of people with cancer by developing next-generation immunotherapies. The company is based in Cambridge, MA, and the CEO of the company is Briggs W. Morrison. The company's T-bolt™ therapies are designed to target previously unreachable cancer cell targets with high precision. Crossbow's approach is efficient and selective, allowing them to target the entire universe of cancer proteins, which expands the potential of antibody therapy to address many types of cancer. | Pharmaceuticals: Major | Chief Executive Officer | |
SALARIUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 33 |
Zuid-Korea | 13 |
Canada | 4 |
Verenigd Koninkrijk | 2 |
Nederland | 2 |
Sectoraal
Health Technology | 27 |
Consumer Services | 10 |
Commercial Services | 8 |
Finance | 5 |
Energy Minerals | 3 |
Operationeel
Director/Board Member | 35 |
Chief Executive Officer | 13 |
President | 11 |
Independent Dir/Board Member | 8 |
Chief Tech/Sci/R&D Officer | 4 |
Sterkste connecties
Insiders | |
---|---|
Briggs Morrison | 26 |
Jun Kim | 9 |
Paul Lammers | 8 |
Sung-Wuk Kim | 6 |
Benjamin R. Cowen | 6 |
Jae-Joon Kim | 3 |
Sungsoo Koh | 1 |
- Beurs
- Insiders
- Bong-Yong Lee
- Bedrijfsconnecties